Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome

Lancet. 1988 Jul 23;2(8604):183-6. doi: 10.1016/s0140-6736(88)92287-8.

Abstract

Sera from 13 of 14 children with acute haemolytic uraemic syndrome (HUS) contained complement-fixing IgG and IgM antibodies that lysed cultured human umbilical vein endothelial cells. In 3 of 3 sera tested, no lysis of dermal fibroblasts was observed. The endothelial cell antigen was lost after treatment of the cells with gamma interferon. In contrast, only 3 of 5 adult patients with acute, non-relapsing, thrombotic thrombocytopenic purpura (TTP) had lytic anti-endothelial antibodies and only 1 of these recognised an antigen lost upon gamma interferon treatment. None of 32 control sera contained lytic anti-endothelial cell antibodies. These data suggest that HUS involves a disorder of immunoregulation and that a unique class of anti-endothelial cell antibodies is produced that may take part in the pathogenesis of vascular injury in HUS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Autoantibodies / isolation & purification*
  • Child
  • Child, Preschool
  • Cytotoxicity, Immunologic*
  • Endothelium, Vascular / immunology*
  • Female
  • Hemolytic-Uremic Syndrome / immunology*
  • Hemolytic-Uremic Syndrome / therapy
  • Humans
  • Immunoglobulin G / isolation & purification
  • Immunoglobulin M / isolation & purification
  • Infant
  • Interferon-gamma / therapeutic use
  • Male
  • Purpura, Thrombotic Thrombocytopenic / immunology*
  • Purpura, Thrombotic Thrombocytopenic / therapy

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulin M
  • Interferon-gamma